Scientific Program

Thursday, December 7, 2017
Time Topic Session
1:00pm-5:30pm
Registration Sign-In
6:45pm-7:00pm
Opening Remarks
Alphonse E. Sirica, Ph.D., M.S. (VCU) 
SESSION 1: Hepatobiliary Cancer Risk Conditions and Prevention Strategies

Chairs: Anna Mae Diehl, M.D., Hashem B. El-Serag, M.D., M.P.H.
Key Topic Areas: Focus on known risk conditions for primary liver cancers, with added emphasis on prevention strategies.

Time Presentation Title and Speaker* Ϯ
7:00pm-7:30pm
The changing etiology of liver cancer, challenges for the next 20 years

John D. Groopman, Ph.D. (Johns Hopkins)

7:30pm-8:00pm 
Prevention of hepatitis C related hepatocellular carcinoma

Hashem B. El-Serag, M.D., M.P.H. (Baylor College of Medicine)

8:00pm-8:30pm 
Liver repair and risk for liver cancer

Anna Mae Diehl, M.D. (Duke)

8:30pm-8:45pm 
Refreshment Break 
8:45pm-9:15pm
Steatohepatitis accelerates HCC development in mice

Gyongyi Szabo, M.D., Ph.D. (UMass)

9:15pm-9:45pm
Novel molecular approaches to HCC risk assessment and prevention

Laura Beretta, Ph.D. (MD Anderson)

Friday, December 8, 2017
Saturday, December 9, 2017
Sunday, December 10, 2017

*Oral presentations by Invited Speakers will be 25 minutes, with an additional 5 minutes for questions. Abstract-driven short talks will be 10 minutes, with 5 additional minutes for questions.

Ϯ Titles of individual oral presentations provided by the Invited Speakers are presumptive and may change to reflect new key basic and translational research findings and biomedical advances.           

 

Hepatobiliary Cancers Evaluation Form